Adnan GÜNDOĞDU, Hikmet SERT, Nurhilal KIZILTOPRAK, Meryem Gözde KILIÇ, Mustafa Kağan BAŞDOĞAN, Güney ÖZKAYA, İbrahim AYDIN
Turkish Journal of Colorectal Disease - 2026;36(3):73-79
Aim: The present study was designed to evaluate early surgical outcomes, recurrence rates, and exploratory patient-reported outcome measures between LigaSure excisional hemorrhoidectomy and non-Doppler-guided hemorrhoidal artery ligation with mucopexy in patients with Grade IV hemorrhoidal disease. Method: A retrospective cohort study was performed involving 92 consecutively included patients treated for Grade IV hemorrhoidal disease in a single high-volume center between January 2021 and July 2024. Participants were allocated to either LigaSure hemorrhoidectomy (n=46) or non-Doppler-guided hemorrhoidal artery ligation with mucopexy (n=46). Postoperative pain, complications, recurrence, and patient-reported outcomes were assessed, with follow-up at 6 months. Results: Early postoperative pain and complication rates did not differ significantly across groups. However, recurrence at 6 months was significantly higher in the non-Doppler ligation with mucopexy group than in the LigaSure group (30.4% vs. 10.9%, p=0.018). Exploratory patient-reported outcomes at 6 months favored LigaSure hemorrhoidectomy in terms of daily activity, comfort, social functioning, and psychological well-being. Conclusion: In patients with Grade IV hemorrhoidal disease, non-Doppler-guided hemorrhoidal artery ligation with mucopexy was associated with higher short-term recurrence rates without demonstrating clear advantages in early postoperative or patient-reported outcomes compared with LigaSure hemorrhoidectomy. Exploratory patient-reported outcome findings should be interpreted cautiously due to the absence of validated assessment tools and preoperative baseline measurements. Careful patient selection is warranted, and extended follow-up is needed to confirm the present observations.